Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Capital Reinvestment Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Capital Reinvestment Ratio of 0.09x as of September 2024, meaning it reinvests 0% of its operating cash flow (TL33.37 Million) in capital expenditures (TL2.91 Million). See how leveraged is Oncosem Onkolojik Sistemler Sanayi ve Ti's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Capital Reinvestment Ratio (2022–2022)
This chart tracks Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s Capital Reinvestment Ratio across 1 annual periods. Check Oncosem Onkolojik Sistemler Sanayi ve Ti investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2022–2022)
Year-by-year Capital Reinvestment Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2022 to 2022. For live market cap and broader valuation context, see Oncosem Onkolojik Sistemler Sanayi ve Ti market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.49x | TL52.69 Million | TL26.02 Million | — |